Gilead Sciences buying Immunomedics in $21 billion deal
Shares of the cancer drug specialist Immunomedics have more than doubled before the opening bell, a day after its sale t...
Shares of the cancer drug specialist Immunomedics have more than doubled before the opening bell, a day after its sale t...
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a t...
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderat...
Gilead Sciences Incsaid on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in Ind...
The first results are in for an experimental antiviral drug against the new coronavirus
There is a smattering of green amid all that red on Wall Street